Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider.

Krieckaert C, Hernández-Breijo B, Gehin JE, le Mélédo G, Balsa A, Jani M, Mulleman D, Navarro-Compan V, Wolbink G, Isaac J, van Tubergen A

Open source

DOI
10.1136/rmdopen-2022-002216
Published
2022 Jun
Container
RMD open
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/rmdopen-2022-002216,
  title = {Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider.},
  author = {Krieckaert C and Hernández-Breijo B and Gehin JE and le Mélédo G and Balsa A and Jani M and Mulleman D and Navarro-Compan V and Wolbink G and Isaac J and van Tubergen A},
  year = {2022},
  journal = {RMD open},
  doi = {10.1136/rmdopen-2022-002216},
  url = {https://doi.org/10.1136/rmdopen-2022-002216}
}

RIS

TY  - JOUR
TI  - Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider.
AU  - Krieckaert C
AU  - Hernández-Breijo B
AU  - Gehin JE
AU  - le Mélédo G
AU  - Balsa A
AU  - Jani M
AU  - Mulleman D
AU  - Navarro-Compan V
AU  - Wolbink G
AU  - Isaac J
AU  - van Tubergen A
PY  - 2022
JO  - RMD open
DO  - 10.1136/rmdopen-2022-002216
UR  - https://doi.org/10.1136/rmdopen-2022-002216
ER  - 

APA

C, K., B, H., JE, G., G, L. M., A, B., M, J., D, M., V, N., G, W., J, I., & A, V. T. (2022). Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider.. RMD open. https://doi.org/10.1136/rmdopen-2022-002216

Source records